Increasing Physical Activity Among Medical Inpatients by Digital Nudging of Patients and Staff (IPAMINA)

May 21, 2025 updated by: Christian Dall, Bispebjerg Hospital

Increasing Physical Activity Among Medical Inpatients by Digital Nudging of Patients and Staff - A Cluster Randomised Multicentre Study

Sedentary behaviour among medical inpatients is strongly associated with hospital-associated functional decline and poses a severe threat to patients' functional capacity and independency. High human and socioeconomic costs underline the urgency to find solutions to this world-wide problem.

Objective: This multicentre study, including a total of 400 patients from Copenhagen, Aalborg, Tórshavn, and Nuuk, will assess the effect of a digital intervention that aims to reduce sedentary behaviour and increase physical activity in medical inpatients.

Intervention: Digital feedback and nudging regarding the patients' physical activity levels to patients and healthcare staff Design: Stepped-wedge cluster randomised multicentre trial Primary outcome: Daily average time of patients' physical activity (minutes).

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Denmark
    • Region Hovedstaden
      • Copenhagen, Region Hovedstaden, Denmark
        • Recruiting
        • Bispebjerg Hospital
        • Contact:
        • Contact:
          • Dall
    • Region Nordjylland
      • Hobro, Region Nordjylland, Denmark
        • Recruiting
        • Aalborg University Hospital
        • Contact:
          • Michael S Rathleff, Professor, Dr. Med.
          • Phone Number: +45 22117002
          • Email: misr@hst.aau.dk
        • Contact:
          • Rathleff
  • Faroe Islands
  • Greenland
      • Nuuk, Greenland
        • Recruiting
        • Queen Ingrids Hospital
        • Contact:
          • Sonja Sørensen, MSc., Physiotherapist
          • Phone Number: +299 344741
          • Email: sonj@peqqik.gl

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Admitted to one of the participating wards
  • Has understood and signed informed consent
  • Reads and understands Danish, Faroese, Greenlandic or English

Exclusion Criteria:

  • Has an expected hospitalisation less than 24 hours after potential recruitment
  • Is not able to give informed consent to participate in the study
  • Has allergy towards band aid
  • Not able to (shortly) stand in an upright position even with maximal assistance
  • There are contraindications for the patient to mobilise or be physically active due to unstabilized acute medical conditions, including, but not limited to, acute aortic dissection, -myocardial infarction, -pulmonary embolism, -sepsis.

  • There are ethical concerns regarding the patients' participation in the study, including, but not limited to, the patient being:

    • In the terminal phase of life
    • In a crisis state regarding their disease/situation and deemed unfit for participation

To ensure medically responsible inclusion of patients, the project personnel will consult and confer with the treatment responsible medical doctor, or their delegate, before including a potential participant for the trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Control
Measurement of physical activity
Other: Measurement of physical activity
Measurement of physical activity by accelerometer
Experimental: Intervention
Digital feedback and nudging to participant and staff regarding participants' physical activity levels
Other: Digital nudging
Digital feedback and nudging to participants (patients) and staff, based on participants' physical activity measurements, aiming to increase patients' physical activity and reduce sedentary time

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Daily average time of participants' physical activity (minutes)
Time Frame: From enrollment to end of trial participation (maximum 7 days)
From enrollment to end of trial participation (maximum 7 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bispebjerg Hospital

Investigators

  • Principal Investigator: Christian H Dall, Associate professor, PhD, Bispebjerg Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 19, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

May 14, 2025

First Submitted That Met QC Criteria

May 14, 2025

First Posted (Actual)

May 22, 2025

Study Record Updates

Last Update Posted (Actual)

May 25, 2025

Last Update Submitted That Met QC Criteria

May 21, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • VMK-2403916

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Measurement of physical activity

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe